{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T07:56:58Z","timestamp":1794988618423,"version":"4.9.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"DOI":"10.1038\/s41586-026-11153-8","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:03:27Z","timestamp":1791385407000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["tRNA dosage regulates lineage dependency and resistance in prostate cancer"],"prefix":"10.1038","author":[{"given":"Yeon Soo","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6661-3024","authenticated-orcid":false,"given":"Sonali","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ava","family":"Tsou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Shiuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia L.","family":"Wladyka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmytro","family":"Rudoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Yeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha L.","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilsa M.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mridu","family":"Kapur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5698-5627","authenticated-orcid":false,"given":"Marek","family":"Sobczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Katanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2944-046X","authenticated-orcid":false,"given":"Amin M.","family":"Bayat Tork","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8577-2613","authenticated-orcid":false,"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5451-5726","authenticated-orcid":false,"given":"Peter S.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7578-7272","authenticated-orcid":false,"given":"Gavin","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Haffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9244-3807","authenticated-orcid":false,"given":"Eva","family":"Corey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colm","family":"Morrissey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9749-8591","authenticated-orcid":false,"given":"Yuzhuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6145-4303","authenticated-orcid":false,"given":"Arvind R.","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6570-2180","authenticated-orcid":false,"given":"John K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Ackerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1096-8405","authenticated-orcid":false,"given":"Tao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0897-1050","authenticated-orcid":false,"given":"Andrew C.","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"11153_CR1","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/nrc1947","volume":"6","author":"LA Garraway","year":"2006","unstructured":"Garraway, L. A. & Sellers, W. R. Lineage dependency and lineage-survival oncogenes in human cancer. Nat. Rev. Cancer 6, 593\u2013602 https:\/\/doi.org\/10.1038\/nrc1947 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"11153_CR2","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41571-020-0340-z","volume":"17","author":"A Quintanal-Villalonga","year":"2020","unstructured":"Quintanal-Villalonga, A. et al. Lineage plasticity in cancer: a shared pathway of therapeutic resistance. Nat. Rev. Clin. Oncol. 17, 360\u2013371 https:\/\/doi.org\/10.1038\/s41571-020-0340-z (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"11153_CR3","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1016\/j.cell.2024.05.051","volume":"187","author":"M Linneberg-Agerholm","year":"2024","unstructured":"Linneberg-Agerholm, M. et al. The primitive endoderm supports lineage plasticity to enable regulative development. Cell 187, 4010\u20134029 https:\/\/doi.org\/10.1016\/j.cell.2024.05.051 (2024).","journal-title":"Cell"},{"key":"11153_CR4","doi-asserted-by":"publisher","DOI":"10.1126\/science.adi7342","volume":"383","author":"MT Tierney","year":"2024","unstructured":"Tierney, M. T. et al. Vitamin A resolves lineage plasticity to orchestrate stem cell lineage choices. Science 383 eadi7342 https:\/\/doi.org\/10.1126\/science.adi7342 (2024).","journal-title":"Science"},{"key":"11153_CR5","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/0092-8674(87)90585-x","volume":"51","author":"RL Davis","year":"1987","unstructured":"Davis, R. L., Weintraub, H. & Lassar, A. B. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51, 987\u20131000 https:\/\/doi.org\/10.1016\/0092-8674(87)90585-x (1987).","journal-title":"Cell"},{"key":"11153_CR6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nature08533","volume":"462","author":"T Graf","year":"2009","unstructured":"Graf, T. & Enver, T. Forcing cells to change lineages. Nature 462, 587\u2013594 https:\/\/doi.org\/10.1038\/nature08533 (2009).","journal-title":"Nature"},{"key":"11153_CR7","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.cell.2017.03.042","volume":"169","author":"Y Ge","year":"2017","unstructured":"Ge, Y. et al. Stem cell lineage infidelity drives wound repair and cancer. Cell 169, 636\u2013650 https:\/\/doi.org\/10.1016\/j.cell.2017.03.042 (2017).","journal-title":"Cell"},{"key":"11153_CR8","doi-asserted-by":"publisher","first-page":"6916","DOI":"10.1158\/1078-0432.CCR-19-1423","volume":"25","author":"H Beltran","year":"2019","unstructured":"Beltran, H. et al. The role of lineage plasticity in prostate cancer therapy resistance. Clin. Cancer Res. 25, 6916\u20136924 https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-1423 (2019).","journal-title":"Clin. Cancer Res."},{"key":"11153_CR9","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1056\/NEJMoa1207506","volume":"367","author":"HI Scher","year":"2012","unstructured":"Scher, H. I. et al. Increased survival with enzalutamide in prostate cancer after chemotherapy. N. Engl. J. Med. 367, 1187\u20131197 https:\/\/doi.org\/10.1056\/NEJMoa1207506 (2012).","journal-title":"N. Engl. J. Med."},{"key":"11153_CR10","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1014618","volume":"364","author":"JS de Bono","year":"2011","unstructured":"de Bono, J. S. et al. Abiraterone and increased survival in metastatic prostate cancer. N. Engl. J. Med. 364, 1995\u20132005 https:\/\/doi.org\/10.1056\/NEJMoa1014618 (2011).","journal-title":"N. Engl. J. Med."},{"key":"11153_CR11","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/bjc.1971.33","volume":"25","author":"MP Cole","year":"1971","unstructured":"Cole, M. P., Jones, C. T. & Todd, I. D. A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI46474. Br. J. Cancer 25, 270\u2013275 https:\/\/doi.org\/10.1038\/bjc.1971.33 (1971).","journal-title":"Br. J. Cancer"},{"key":"11153_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1001\/archsurg.1941.01210140043004","volume":"43","author":"C Huggins","year":"1941","unstructured":"Huggins, C., Stevens, R. E. & Hodges, C. V. Studies on prostate cancer. II. The effects of castration on advanced carcinoma of the prostate gland. Arch. Surg. 43, 209\u2013223 (1941).","journal-title":"Arch. Surg."},{"key":"11153_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.diff.2018.08.005","volume":"103","author":"GR Cunha","year":"2018","unstructured":"Cunha, G. R. et al. Development of the human prostate. Differentiation 103, 24\u201345 https:\/\/doi.org\/10.1016\/j.diff.2018.08.005 (2018).","journal-title":"Differentiation"},{"key":"11153_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/35094009","volume":"1","author":"BJ Feldman","year":"2001","unstructured":"Feldman, B. J. & Feldman, D. The development of androgen-independent prostate cancer. Nat. Rev. Cancer 1, 34\u201345 https:\/\/doi.org\/10.1038\/35094009 (2001).","journal-title":"Nat. Rev. Cancer"},{"key":"11153_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nm972","volume":"10","author":"C Chen","year":"2004","unstructured":"Chen, C. et al. Molecular determinants of resistance to antiandrogen therapy. Nat. Med. 10, 33\u201339 https:\/\/doi.org\/10.1038\/nm972 (2004).","journal-title":"Nat. Med."},{"key":"11153_CR16","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.aah4307","volume":"355","author":"P Mu","year":"2017","unstructured":"Mu, P. et al. SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer. Science 355, 84\u201388 https:\/\/doi.org\/10.1126\/science.aah4307 (2017).","journal-title":"Science"},{"key":"11153_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1126\/science.aah4199","volume":"355","author":"SY Ku","year":"2017","unstructured":"Ku, S. Y. et al. Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance. Science 355, 78\u201383 https:\/\/doi.org\/10.1126\/science.aah4199 (2017).","journal-title":"Science"},{"key":"11153_CR18","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ccell.2017.09.003","volume":"32","author":"EG Bluemn","year":"2017","unstructured":"Bluemn, E. G. et al. Androgen receptor pathway-independent prostate cancer is sustained through FGF signaling. Cancer Cell 32, 474\u2013489 https:\/\/doi.org\/10.1016\/j.ccell.2017.09.003 (2017).","journal-title":"Cancer Cell"},{"key":"11153_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe1505","volume":"376","author":"F Tang","year":"2022","unstructured":"Tang, F. et al. Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets. Science 376, eabe1505 https:\/\/doi.org\/10.1126\/science.abe1505 (2022).","journal-title":"Science"},{"key":"11153_CR20","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nm.4045","volume":"22","author":"H Beltran","year":"2016","unstructured":"Beltran, H. et al. Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. Nat. Med. 22, 298\u2013305 https:\/\/doi.org\/10.1038\/nm.4045 (2016).","journal-title":"Nat. Med."},{"key":"11153_CR21","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1001\/jamaoncol.2017.0751","volume":"3","author":"SG Zhao","year":"2017","unstructured":"Zhao, S. G. et al. Associations of luminal and basal subtyping of prostate cancer with prognosis and response to androgen deprivation therapy. JAMA Oncol. 3, 1663\u20131672 https:\/\/doi.org\/10.1001\/jamaoncol.2017.0751 (2017).","journal-title":"JAMA Oncol."},{"key":"11153_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrm.2017.77","volume":"19","author":"P Schimmel","year":"2018","unstructured":"Schimmel, P. The emerging complexity of the tRNA world: mammalian tRNAs beyond protein synthesis. Nat. Rev. Mol. Cell Biol. 19, 45\u201358 https:\/\/doi.org\/10.1038\/nrm.2017.77 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"11153_CR23","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41422-018-0013-y","volume":"28","author":"T Pan","year":"2018","unstructured":"Pan, T. Modifications and functional genomics of human transfer RNA. Cell Res. 28, 395\u2013404 https:\/\/doi.org\/10.1038\/s41422-018-0013-y (2018).","journal-title":"Cell Res."},{"key":"11153_CR24","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1080\/15476286.2017.1403003","volume":"15","author":"SU Umu","year":"2018","unstructured":"Umu, S. U. et al. A comprehensive profile of circulating RNAs in human serum. RNA Biol. 15, 242\u2013250 https:\/\/doi.org\/10.1080\/15476286.2017.1403003 (2018).","journal-title":"RNA Biol."},{"key":"11153_CR25","doi-asserted-by":"publisher","first-page":"e221","DOI":"10.1371\/journal.pgen.0020221","volume":"2","author":"KA Dittmar","year":"2006","unstructured":"Dittmar, K. A., Goodenbour, J. M. & Pan, T. Tissue-specific differences in human transfer RNA expression. PLoS Genet. 2, e221 https:\/\/doi.org\/10.1371\/journal.pgen.0020221 (2006).","journal-title":"PLoS Genet."},{"key":"11153_CR26","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41556-023-01317-3","volume":"26","author":"L Gao","year":"2024","unstructured":"Gao, L. et al. Selective gene expression maintains human tRNA anticodon pools during differentiation. Nat. Cell Biol. 26, 100\u2013112 https:\/\/doi.org\/10.1038\/s41556-023-01317-3 (2024).","journal-title":"Nat. Cell Biol."},{"key":"11153_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17879-x","volume":"11","author":"O Pinkard","year":"2020","unstructured":"Pinkard, O., McFarland, S., Sweet, T. & Coller, J. Quantitative tRNA-sequencing uncovers metazoan tissue-specific tRNA regulation. Nat. Commun. 11, 4104 https:\/\/doi.org\/10.1038\/s41467-020-17879-x (2020).","journal-title":"Nat. Commun."},{"key":"11153_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30261-3","volume":"13","author":"CP Watkins","year":"2022","unstructured":"Watkins, C. P., Zhang, W., Wylder, A. C., Katanski, C. D. & Pan, T. A multiplex platform for small RNA sequencing elucidates multifaceted tRNA stress response and translational regulation. Nat. Commun. 13, 2491 https:\/\/doi.org\/10.1038\/s41467-022-30261-3 (2022).","journal-title":"Nat. Commun."},{"key":"11153_CR29","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.cell.2014.08.011","volume":"158","author":"H Gingold","year":"2014","unstructured":"Gingold, H. et al. A dual program for translation regulation in cellular proliferation and differentiation. Cell 158, 1281\u20131292 https:\/\/doi.org\/10.1016\/j.cell.2014.08.011 (2014).","journal-title":"Cell"},{"key":"11153_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37843-9","volume":"14","author":"LA Hughes","year":"2023","unstructured":"Hughes, L. A. et al. Copy number variation in tRNA isodecoder genes impairs mammalian development and balanced translation. Nat. Commun. 14, 2210 https:\/\/doi.org\/10.1038\/s41467-023-37843-9 (2023).","journal-title":"Nat. Commun."},{"key":"11153_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.696438","volume":"8","author":"E Lata","year":"2021","unstructured":"Lata, E. et al. RNA polymerase III subunit mutations in genetic diseases. Front. Mol. Biosci. 8, 696438 https:\/\/doi.org\/10.3389\/fmolb.2021.696438 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"11153_CR32","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/s41568-023-00611-4","volume":"23","author":"AM Pinzaru","year":"2023","unstructured":"Pinzaru, A. M. & Tavazoie, S. F. Transfer RNAs as dynamic and critical regulators of cancer progression. Nat. Rev. Cancer 23, 746\u2013761 https:\/\/doi.org\/10.1038\/s41568-023-00611-4 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"11153_CR33","doi-asserted-by":"publisher","first-page":"7268","DOI":"10.1093\/nar\/gkp787","volume":"37","author":"M Pavon-Eternod","year":"2009","unstructured":"Pavon-Eternod, M. et al. tRNA over-expression in breast cancer and functional consequences. Nucleic Acids Res. 37, 7268\u20137280 https:\/\/doi.org\/10.1093\/nar\/gkp787 (2009).","journal-title":"Nucleic Acids Res."},{"key":"11153_CR34","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1242\/bio.019075","volume":"5","author":"J Birch","year":"2016","unstructured":"Birch, J. et al. The initiator methionine tRNA drives cell migration and invasion leading to increased metastatic potential in melanoma. Biol. Open 5, 1371\u20131379 https:\/\/doi.org\/10.1242\/bio.019075 (2016).","journal-title":"Biol. Open"},{"key":"11153_CR35","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1261\/rna.037507.112","volume":"19","author":"M Pavon-Eternod","year":"2013","unstructured":"Pavon-Eternod, M., Gomes, S., Rosner, M. R. & Pan, T. Overexpression of initiator methionine tRNA leads to global reprogramming of tRNA expression and increased proliferation in human epithelial cells. RNA 19, 461\u2013466 https:\/\/doi.org\/10.1261\/rna.037507.112 (2013).","journal-title":"RNA"},{"key":"11153_CR36","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.cell.2016.05.046","volume":"165","author":"H Goodarzi","year":"2016","unstructured":"Goodarzi, H. et al. Modulated expression of specific tRNAs drives gene expression and cancer progression. Cell 165, 1416\u20131427 https:\/\/doi.org\/10.1016\/j.cell.2016.05.046 (2016).","journal-title":"Cell"},{"key":"11153_CR37","doi-asserted-by":"publisher","unstructured":"Li, S. et al. Defined cellular reprogramming of androgen receptor-active prostate cancer to neuroendocrine prostate cancer. Reviewed preprint at eLife https:\/\/doi.org\/10.7554\/eLife.106511.1 (2025).","DOI":"10.7554\/eLife.106511.1"},{"key":"11153_CR38","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/pros.20031","volume":"60","author":"AY Liu","year":"2004","unstructured":"Liu, A. Y. et al. Lineage relationship between LNCaP and LNCaP-derived prostate cancer cell lines. Prostate 60, 98\u2013108 https:\/\/doi.org\/10.1002\/pros.20031 (2004).","journal-title":"Prostate"},{"key":"11153_CR39","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1158\/0008-5472.CAN-13-2921-T","volume":"74","author":"D Lin","year":"2014","unstructured":"Lin, D. et al. High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development. Cancer Res. 74, 1272\u20131283 https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-2921-T (2014).","journal-title":"Cancer Res."},{"key":"11153_CR40","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1056\/NEJMoa1903835","volume":"381","author":"ID Davis","year":"2019","unstructured":"Davis, I. D. et al. Enzalutamide with standard first-line therapy in metastatic prostate cancer. N. Engl. J. Med. 381, 121\u2013131 https:\/\/doi.org\/10.1056\/NEJMoa1903835 (2019).","journal-title":"N. Engl. J. Med."},{"key":"11153_CR41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1903307","volume":"381","author":"KN Chi","year":"2019","unstructured":"Chi, K. N. et al. Apalutamide for metastatic, castration-sensitive prostate cancer. N. Engl. J. Med. 381, 13\u201324 https:\/\/doi.org\/10.1056\/NEJMoa1903307 (2019).","journal-title":"N. Engl. J. Med."},{"key":"11153_CR42","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1056\/NEJMoa2119115","volume":"386","author":"MR Smith","year":"2022","unstructured":"Smith, M. R. et al. Darolutamide and survival in metastatic, hormone-sensitive prostate cancer. N. Engl. J. Med. 386, 1132\u20131142 https:\/\/doi.org\/10.1056\/NEJMoa2119115 (2022).","journal-title":"N. Engl. J. Med."},{"key":"11153_CR43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1158\/1078-0432.CCR-18-1912","volume":"25","author":"H Beltran","year":"2019","unstructured":"Beltran, H. et al. A Phase II trial of the aurora kinase a inhibitor alisertib for patients with castration-resistant and neuroendocrine prostate cancer: efficacy and biomarkers. Clin. Cancer Res. 25, 43\u201351 https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1912 (2019).","journal-title":"Clin. Cancer Res."},{"key":"11153_CR44","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/s1535-6108(03)00197-1","volume":"4","author":"K Ellwood-Yen","year":"2003","unstructured":"Ellwood-Yen, K. et al. Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell 4, 223\u2013238 https:\/\/doi.org\/10.1016\/s1535-6108(03)00197-1 (2003).","journal-title":"Cancer Cell"},{"key":"11153_CR45","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.neuron.2024.01.028","volume":"112","author":"M Kapur","year":"2024","unstructured":"Kapur, M., Molumby, M. J., Guzman, C., Heinz, S. & Ackerman, S. L. Cell-type-specific expression of tRNAs in the brain regulates cellular homeostasis. Neuron 112, 1397\u20131415 https:\/\/doi.org\/10.1016\/j.neuron.2024.01.028 (2024).","journal-title":"Neuron"},{"key":"11153_CR46","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/sj.bjc.6690684","volume":"81","author":"Z Culig","year":"1999","unstructured":"Culig, Z. et al. Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system. Br. J. Cancer 81, 242\u2013251 https:\/\/doi.org\/10.1038\/sj.bjc.6690684 (1999).","journal-title":"Br. J. Cancer"},{"key":"11153_CR47","doi-asserted-by":"publisher","first-page":"20.25.21","DOI":"10.1002\/0471142735.im2005s45","volume":"45","author":"AA Hurwitz","year":"2021","unstructured":"Hurwitz, A. A., Foster, B. A., Allison, J. P., Greenberg, N. M. & Kwon, E. D. The TRAMP mouse as a model for prostate cancer. Curr. Protoc. Immunol. 45, 20.25.21\u201320.25.23 https:\/\/doi.org\/10.1002\/0471142735.im2005s45 (2001).","journal-title":"Curr. Protoc. Immunol."},{"key":"11153_CR48","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.molonc.2013.02.005","volume":"7","author":"M Parisotto","year":"2013","unstructured":"Parisotto, M. & Metzger, D. Genetically engineered mouse models of prostate cancer. Mol. Oncol. 7, 190\u2013205 https:\/\/doi.org\/10.1016\/j.molonc.2013.02.005 (2013).","journal-title":"Mol. Oncol."},{"key":"11153_CR49","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.neuron.2020.07.023","volume":"108","author":"M Kapur","year":"2020","unstructured":"Kapur, M. et al. Expression of the neuronal tRNA n-Tr20 regulates synaptic transmission and seizure susceptibility. Neuron 108, 193\u2013208 https:\/\/doi.org\/10.1016\/j.neuron.2020.07.023 (2020).","journal-title":"Neuron"},{"key":"11153_CR50","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.molcel.2020.03.023","volume":"78","author":"A Gerber","year":"2020","unstructured":"Gerber, A., Ito, K., Chu, C. S. & Roeder, R. G. Gene-specific control of tRNA expression by RNA polymerase II. Mol. Cell 78, 765\u2013778 https:\/\/doi.org\/10.1016\/j.molcel.2020.03.023 (2020).","journal-title":"Mol. Cell"},{"key":"11153_CR51","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/nsmb.1801","volume":"17","author":"AJ Oler","year":"2010","unstructured":"Oler, A. J. et al. Human RNA polymerase III transcriptomes and relationships to Pol II promoter chromatin and enhancer-binding factors. Nat. Struct. Mol. Biol. 17, 620\u2013628 https:\/\/doi.org\/10.1038\/nsmb.1801 (2010).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"11153_CR52","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41586-020-2493-4","volume":"583","author":"ENCODE Project Consortium","year":"2020","unstructured":"ENCODE Project Consortium et al. Expanded encyclopaedias of DNA elements in the human and mouse genomes. Nature 583, 699\u2013710 https:\/\/doi.org\/10.1038\/s41586-020-2493-4 (2020).","journal-title":"Nature"},{"key":"11153_CR53","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/cells7030017","volume":"7","author":"A Bochynska","year":"2018","unstructured":"Bochynska, A., Luscher-Firzlaff, J. & Luscher, B. Modes of interaction of KMT2 histone h3 lysine 4 methyltransferase\/COMPASS complexes with chromatin. Cells 7, 17 https:\/\/doi.org\/10.3390\/cells7030017 (2018).","journal-title":"Cells"},{"key":"11153_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagrm.2019.194434","volume":"1862","author":"AA Morera","year":"2019","unstructured":"Morera, A. A., Ahmed, N. S. & Schwartz, J. C. TDP-43 regulates transcription at protein-coding genes and Alu retrotransposons. Biochim. Biophys. Acta, Gene Regul. Mech. 1862, 194434 https:\/\/doi.org\/10.1016\/j.bbagrm.2019.194434 (2019).","journal-title":"Biochim. Biophys. Acta, Gene Regul. Mech."},{"key":"11153_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.105053","volume":"299","author":"M Zhou","year":"2023","unstructured":"Zhou, M. et al. ZBTB40 is a telomere-associated protein and protects telomeres in human ALT cells. J. Biol. Chem. 299, 105053 https:\/\/doi.org\/10.1016\/j.jbc.2023.105053 (2023).","journal-title":"J. Biol. Chem."},{"key":"11153_CR56","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nsmb.1806","volume":"17","author":"A Barski","year":"2010","unstructured":"Barski, A. et al. Pol II and its associated epigenetic marks are present at Pol III-transcribed noncoding RNA genes. Nat. Struct. Mol. Biol. 17, 629\u2013634 https:\/\/doi.org\/10.1038\/nsmb.1806 (2010).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"11153_CR57","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.cell.2013.01.052","volume":"152","author":"SM Lauberth","year":"2013","unstructured":"Lauberth, S. M. et al. H3K4me3 interactions with TAF3 regulate preinitiation complex assembly and selective gene activation. Cell 152, 1021\u20131036 https:\/\/doi.org\/10.1016\/j.cell.2013.01.052 (2013).","journal-title":"Cell"},{"key":"11153_CR58","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nsmb.1794","volume":"17","author":"Z Moqtaderi","year":"2010","unstructured":"Moqtaderi, Z. et al. Genomic binding profiles of functionally distinct RNA polymerase III transcription complexes in human cells. Nat. Struct. Mol. Biol. 17, 635\u2013640 https:\/\/doi.org\/10.1038\/nsmb.1794 (2010).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"11153_CR59","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nrm.2017.91","volume":"19","author":"G Hanson","year":"2018","unstructured":"Hanson, G. & Coller, J. Codon optimality, bias and usage in translation and mRNA decay. Nat. Rev. Mol. Cell Biol. 19, 20\u201330 https:\/\/doi.org\/10.1038\/nrm.2017.91 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"11153_CR60","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.molcel.2018.06.041","volume":"71","author":"AM Darnell","year":"2018","unstructured":"Darnell, A. M., Subramaniam, A. R. & O\u2019Shea, E. K. Translational control through differential ribosome pausing during amino acid limitation in mammalian cells. Mol Cell 71, 229\u2013243 https:\/\/doi.org\/10.1016\/j.molcel.2018.06.041 (2018).","journal-title":"Mol Cell"},{"key":"11153_CR61","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-021-04246-z","volume":"601","author":"L Xiao","year":"2022","unstructured":"Xiao, L. et al. Targeting SWI\/SNF ATPases in enhancer-addicted prostate cancer. Nature 601, 434\u2013439 https:\/\/doi.org\/10.1038\/s41586-021-04246-z (2022).","journal-title":"Nature"},{"key":"11153_CR62","doi-asserted-by":"publisher","DOI":"10.1172\/JCI175217","volume":"134","author":"SY Ku","year":"2024","unstructured":"Ku, S. Y. et al. Notch signaling suppresses neuroendocrine differentiation and alters the immune microenvironment in advanced prostate cancer. J. Clin. Invest. 134, e175217 https:\/\/doi.org\/10.1172\/JCI175217 (2024).","journal-title":"J. Clin. Invest."},{"key":"11153_CR63","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aav0891","volume":"11","author":"L Puca","year":"2019","unstructured":"Puca, L. et al. Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer. Sci. Transl. Med. 11, eaav0891 https:\/\/doi.org\/10.1126\/scitranslmed.aav0891 (2019).","journal-title":"Sci. Transl. Med."},{"key":"11153_CR64","doi-asserted-by":"publisher","unstructured":"Chen, S. et al. Discovery of a tRNA-regulatory transcription factor that suppresses breast cancer metastasis. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.04.26.650725 (2025).","DOI":"10.1101\/2025.04.26.650725"},{"key":"11153_CR65","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41586-022-04533-3","volume":"604","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. AAV-delivered suppressor tRNA overcomes a nonsense mutation in mice. Nature 604, 343\u2013348 https:\/\/doi.org\/10.1038\/s41586-022-04533-3 (2022).","journal-title":"Nature"},{"key":"11153_CR66","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41586-023-06133-1","volume":"618","author":"S Albers","year":"2023","unstructured":"Albers, S. et al. Engineered tRNAs suppress nonsense mutations in cells and in vivo. Nature 618, 842\u2013848 https:\/\/doi.org\/10.1038\/s41586-023-06133-1 (2023).","journal-title":"Nature"},{"key":"11153_CR67","doi-asserted-by":"publisher","first-page":"D93","DOI":"10.1093\/nar\/gkn787","volume":"37","author":"PP Chan","year":"2009","unstructured":"Chan, P. P. & Lowe, T. M. GtRNAdb: a database of transfer RNA genes detected in genomic sequence. Nucleic Acids Res. 37, D93\u2013D97 https:\/\/doi.org\/10.1093\/nar\/gkn787 (2009).","journal-title":"Nucleic Acids Res."},{"key":"11153_CR68","doi-asserted-by":"publisher","first-page":"D184","DOI":"10.1093\/nar\/gkv1309","volume":"44","author":"PP Chan","year":"2016","unstructured":"Chan, P. P. & Lowe, T. M. GtRNAdb 2.0: an expanded database of transfer RNA genes identified in complete and draft genomes. Nucleic Acids Res. 44, D184\u2013D189 https:\/\/doi.org\/10.1093\/nar\/gkv1309 (2016).","journal-title":"Nucleic Acids Res."},{"key":"11153_CR69","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/bs.mie.2024.11.009","volume":"711","author":"LR Frietze","year":"2025","unstructured":"Frietze, L. R. & Pan, T. Bioinformatics of simultaneous, quantitative measurements of full-length tRNA and tRNA fragments by MSR sequencing. Methods Enzymol. 711, 312\u2013323 https:\/\/doi.org\/10.1016\/bs.mie.2024.11.009 (2025).","journal-title":"Methods Enzymol."},{"key":"11153_CR70","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.ccr.2006.09.005","volume":"10","author":"H Hieronymus","year":"2006","unstructured":"Hieronymus, H. et al. Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. Cancer Cell 10, 321\u2013330 https:\/\/doi.org\/10.1016\/j.ccr.2006.09.005 (2006).","journal-title":"Cancer Cell"},{"key":"11153_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29963-5","volume":"13","author":"S Nouruzi","year":"2022","unstructured":"Nouruzi, S. et al. ASCL1 activates neuronal stem cell-like lineage programming through remodeling of the chromatin landscape in prostate cancer. Nat. Commun. 13, 2282 https:\/\/doi.org\/10.1038\/s41467-022-29963-5 (2022).","journal-title":"Nat. Commun."},{"key":"11153_CR72","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41586-023-06130-4","volume":"618","author":"A Gavish","year":"2023","unstructured":"Gavish, A. et al. Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours. Nature 618, 598\u2013606 https:\/\/doi.org\/10.1038\/s41586-023-06130-4 (2023).","journal-title":"Nature"},{"key":"11153_CR73","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1038\/s41388-021-02157-x","volume":"41","author":"L de Wet","year":"2022","unstructured":"de Wet, L. et al. SOX2 mediates metabolic reprogramming of prostate cancer cells. Oncogene 41, 1190\u20131202 https:\/\/doi.org\/10.1038\/s41388-021-02157-x (2022).","journal-title":"Oncogene"},{"key":"11153_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-7-64","volume":"7","author":"UR Chandran","year":"2007","unstructured":"Chandran, U. R. et al. Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process. BMC Cancer 7, 64 https:\/\/doi.org\/10.1186\/1471-2407-7-64 (2007).","journal-title":"BMC Cancer"},{"key":"11153_CR75","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/ng1935","volume":"39","author":"SA Tomlins","year":"2007","unstructured":"Tomlins, S. A. et al. Integrative molecular concept modeling of prostate cancer progression. Nat. Genet. 39, 41\u201351 https:\/\/doi.org\/10.1038\/ng1935 (2007).","journal-title":"Nat. Genet."},{"key":"11153_CR76","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/01926230390173842","volume":"31","author":"A Suttie","year":"2003","unstructured":"Suttie, A. et al. A grading scheme for the assessment of proliferative lesions of the mouse prostate in the TRAMP model. Toxicol. Pathol. 31, 31\u201338 https:\/\/doi.org\/10.1080\/01926230390173842 (2003).","journal-title":"Toxicol. Pathol."},{"key":"11153_CR77","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0002-9440(10)64228-9","volume":"161","author":"JH Park","year":"2002","unstructured":"Park, J. H. et al. Prostatic intraepithelial neoplasia in genetically engineered mice. Am. J. Pathol. 161, 727\u2013735 https:\/\/doi.org\/10.1016\/S0002-9440(10)64228-9 (2002).","journal-title":"Am. J. Pathol."},{"key":"11153_CR78","doi-asserted-by":"publisher","first-page":"112840","DOI":"10.1016\/j.celrep.2023.112840","volume":"42","author":"SL Schuster","year":"2023","unstructured":"Schuster, S. L. et al. Multi-level functional genomics reveals molecular and cellular oncogenicity of patient-based 3\u2032 untranslated region mutations. Cell Rep. 42, 112840 https:\/\/doi.org\/10.1016\/j.celrep.2023.112840 (2023).","journal-title":"Cell Rep."},{"key":"11153_CR79","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.ccell.2023.03.021","volume":"41","author":"S Jana","year":"2023","unstructured":"Jana, S. et al. Transcriptional-translational conflict is a barrier to cellular transformation and cancer progression. Cancer Cell 41, 853\u2013870 https:\/\/doi.org\/10.1016\/j.ccell.2023.03.021 (2023).","journal-title":"Cancer Cell"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-11153-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-11153-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-11153-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:01:49Z","timestamp":1792706509000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-11153-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":79,"alternative-id":["11153"],"URL":"https:\/\/doi.org\/10.1038\/s41586-026-11153-8","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.C.H. served as a paid consultant and received honoraria from Pfizer and Astra Zeneca and has received research funding from Merck, Novartis, Genentech, Promicell and Bristol Myers Squibb. C.M. has received funds from Genentech, Janssen and Novartis unrelated to the current work. E.C. served as a paid consultant to DotQuant and received institutional sponsored research funding unrelated to this work from Astra Zeneca, AbbVie, Gilead, Sanofi, Zenith Epigenetics, Bayer Pharmaceuticals, Forma Therapeutics, Genentech, GSK, Janssen Research, Kronos Bio, Foghorn Therapeutics, K36 Therapeutics and MacroGenics. S.L.A. is a member of the scientific advisory board of Tevard Biosciences. P.S.N. served as a paid consultant and received honoraria from Pfizer, Astrazeneca, Genentech and received research funding from Janssen from work unrelated to the current study. G.H. received research support from Pfizer and has consulted for Quest Diagnostics; all activities are unrelated to this work. A.C.H. serves on the scientific advisory board of Interdict Bio.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}